Relating To Pharmacists. [SB-187]
Authorizes pharmacists to practice clinical pharmacy, including providing patient care services. Defines "clinical pharmacy agreement", "patient care services", and "practice of clinical pharmacy". Requires all insurers in the State, including health benefit plans under chapter 87A, Hawaii Revised Statutes, and medicaid managed care programs, to reimburse pharmacists who provide patient care services.
SB-187: Relating To Pharmacists.
Sponsored by: Sen. Josh Green
Introduced. on 01/20/2017
HB-4: Amends and adds to existing law to provide that prescribing tobacco cessation products is within the practice of pharmacy; and to provide that pharmacists may prescribe tobacco cessation products under certain circumstances.
Sponsored by: Rep.
Reported Signed By Governor On February 16, 2017 Session Law Chapter 25 Effective: 07/01/2017 on 02/16/2017
You have voted HB-4: Amends and adds to existing law to provide that prescribing tobacco cessation products is within the practice of pharmacy; and to provide that pharmacists may prescribe tobacco cessation products under certain circumstances..
HB-3: Amends and adds to existing law to provide that prescribing tuberculin purified protein derivative products is within the practice of pharmacy; and to provide that a pharmacist may prescribe and administer a tuberculin purified protein derivative product under certain circumstances.
Sponsored by: Rep.
Reported Signed By Governor On February 16, 2017 Session Law Chapter 23 Effective: 07/01/2017 on 02/16/2017
You have voted HB-3: Amends and adds to existing law to provide that prescribing tuberculin purified protein derivative products is within the practice of pharmacy; and to provide that a pharmacist may prescribe and administer a tuberculin purified protein derivative product under certain circumstances..
Sponsored by: Sen. Shenna Bellows
In Possession Of The Senate When The Senate Adjourned Sine Die And Placed In The Legislative Files (dead). on 08/02/2017
Prescription Monitoring Program; disclosure of information to certain physicians or pharmacists. [SB-1484]
Prescription Monitoring Program. Provides that the information in the possession of the Prescription Monitoring Program disclosed by the Director of Health Professions about a specific recipient who is a member of a Virginia Medicaid managed care program to a physician or pharmacist employed by the Virginia Medicaid managed care program may be disclosed to such physician's or pharmacist's clinical designee who holds a multistate licensure privilege to practice nursing or a license issued by a health regulatory board within the Department of Health
(continued...)
SB-1484: Prescription Monitoring Program; disclosure of information to certain physicians or pharmacists.
Sponsored by: Sen. Emmett Hanger
Governor: Acts Of Assembly Chapter Text (chap0186) on 02/23/2017
Controlled substances; limits on prescription containing opioids. [HB-1898]
Limits on prescription of controlled substances containing opioids. Prohibits a prescriber providing treatment for a patient in an emergency department of a corporation, facility, or institution licensed, owned, or operated by the Commonwealth to provide health care from prescribing a controlled substance containing an opioid in a quantity greater than a three-day supply, as determined in accordance with the prescriber's directions for use. The bill also prohibits a pharmacist from dispensing a controlled substance containing an opioid pursuant
(continued...)
HB-1898: Controlled substances; limits on prescription containing opioids.
Sponsored by: Sen. John Bell
Left In Health, Welfare And Institutions on 02/07/2017
Dispensing of naloxone; patient-specific order not required. [HB-1750]
Dispensing of naloxone; patient-specific order not required. Provides that a pharmacist may dispense naloxone in the absence of a patient-specific prescription pursuant to a standing order issued by the Commissioner of Health authorizing the dispensing of naloxone or other opioid antagonist used for overdose reversal in the absence of an oral or written order for a specific patient issued by a prescriber and in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health.
HB-1750: Dispensing of naloxone; patient-specific order not required.
Sponsored by: Rep. John O'Bannon
Governor: Acts Of Assembly Chapter Text (chap0174) on 02/23/2017
Telemedicine, practice of; prescribing controlled substances. [SB-1009]
Practice of telemedicine; prescribing. Provides that a health care practitioner who performs or has performed an appropriate examination of the patient, either physically or by the use of instrumentation and diagnostic equipment, for the purpose of establishing a bona fide practitioner-patient relationship may prescribe Schedule II through VI controlled substances to the patient, provided that the prescribing of such controlled substance is in compliance with federal requirements for the practice of telemedicine. The bill also authorizes the Board
(continued...)
SB-1009: Telemedicine, practice of; prescribing controlled substances.
Sponsored by: Sen. George Barker
Governor: Acts Of Assembly Chapter Text (chap0058) on 02/20/2017
Prescription drugs; purpose of labeling. [HB-1424]
Labeling of prescription drugs; purpose. Requires pharmacists to include on any label placed on the container in which any drug dispensed pursuant to a prescription is placed the purpose for which the drug has been prescribed and requires written prescriptions issued by prescribers to include the purpose for which the drug is prescribed.
HB-1424: Prescription drugs; purpose of labeling.
Sponsored by: Rep. Mark Cole
Left In Health, Welfare And Institutions on 02/07/2017